C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/02 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2343193
The invention relates to an improved stereoselective heterogenous catalytic reductive amination between ethyl 2-oxo-4-phenylbutyrate and alanylproline using hydrogen, a catalyst and one or more additives to produce the ACE inhibitor, enalapril.
L'invention concerne un procédé stéréoselectif amélioré pour réaliser une amination de réduction catalytique hétérogène entre 2-oxo-4-phénylbutyrate d'éthyle et alanylproline. Le procédé met en oeuvre de l'hydrogène, un catalyseur et un ou plusieurs additifs pour produire l'enalapril, inhibiteur de l'enzyme de conversion (ACE).
Huffman Mark A.
Leblond Carl
Reider Paul J.
Sun Yongkui
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Improved stereoselective process for enalapril does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved stereoselective process for enalapril, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved stereoselective process for enalapril will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1804737